Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Computer Technologies Department, ITMO University, Saint Petersburg, Russia.
Cell Res. 2019 May;29(5):406-419. doi: 10.1038/s41422-019-0161-8. Epub 2019 Apr 2.
Liver Kinase B1 (LKB1) plays a key role in cellular metabolism by controlling AMPK activation. However, its function in dendritic cell (DC) biology has not been addressed. Here, we find that LKB1 functions as a critical brake on DC immunogenicity, and when lost, leads to reduced mitochondrial fitness and increased maturation, migration, and T cell priming of peripheral DCs. Concurrently, loss of LKB1 in DCs enhances their capacity to promote output of regulatory T cells (Tregs) from the thymus, which dominates the outcome of peripheral immune responses, as suggested by increased resistance to asthma and higher susceptibility to cancer in CD11c mice. Mechanistically, we find that loss of LKB1 specifically primes thymic CD11b DCs to facilitate thymic Treg development and expansion, which is independent from AMPK signalling, but dependent on mTOR and enhanced phospholipase C β1-driven CD86 expression. Together, our results identify LKB1 as a critical regulator of DC-driven effector T cell and Treg responses both in the periphery and the thymus.
肝激酶 B1(LKB1)通过控制 AMPK 激活在细胞代谢中发挥关键作用。然而,其在树突状细胞(DC)生物学中的功能尚未得到解决。在这里,我们发现 LKB1 是 DC 免疫原性的关键制动因素,当失去 LKB1 时,会导致线粒体适应性降低和成熟度增加,以及外周 DC 的迁移和 T 细胞启动增加。同时,DC 中 LKB1 的缺失增强了它们从胸腺中促进调节性 T 细胞(Treg)输出的能力,这主导了外周免疫反应的结果,如哮喘抵抗力增加和癌症易感性增加的 CD11c 小鼠所表明的那样。从机制上讲,我们发现 LKB1 特异性地启动胸腺 CD11b DC,以促进胸腺 Treg 的发育和扩增,这独立于 AMPK 信号,但依赖于 mTOR 和增强的 PLCβ1 驱动的 CD86 表达。总之,我们的结果表明 LKB1 是 DC 驱动的效应 T 细胞和 Treg 反应在周围和胸腺中的关键调节剂。